Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3651)
All Articles published online
|
Sep 14, 2011 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Wei YG, Liu F, Li B, Chen X, Ma Y, Yan LN, Wen TF, Xu MQ, Wang WT, Yang JY. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i34/3941.htm |
| Number | Citing Articles |
| 1 |
Chih-Jung Chen, Wen-Wei Sung, Tzu-Cheng Su, Mu-Kuan Chen, Pei-Ru Wu, Kun-Tu Yeh, Jiunn-Liang Ko, Huei Lee. High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients. Clinica Chimica Acta 2013; 415: 25 doi: 10.1016/j.cca.2012.09.009
|
| 2 |
Armin Hirbod-Mobarakeh, Ali Akbar Amirzargar, Behrouz Nikbin, Mohammad Hossein Nicknam, Anton Kutikhin, Nima Rezaei. Cancer Immunology. 2015; : 295 doi: 10.1007/978-3-662-44006-3_17
|
| 3 |
Chao Yang, Xiang Ma, Dongxiao Liu, Younan Wang, Ran Tang, Yi Zhu, Zekuan Xu, Li Yang. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population. Tumor Biology 2014; 35(12): 12545 doi: 10.1007/s13277-014-2574-9
|
| 4 |
Yan-Hui Shi, Dong-Mei Zhao, Yue-Fei Wang, Xue Li, Man-Ru Ji, Dan-Na Jiang, Bai-Ping Xu, Li Zhou, Chang-Zhu Lu, Bin Wang. The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep30809
|
| 5 |
Zhibin Yu, Qing Liu, Chen Huang, Minghua Wu, Guiyuan Li. The Interleukin 10 −819C/T Polymorphism and Cancer Risk: A HuGE Review and Meta-Analysis of 73 Studies Including 15,942 Cases and 22,336 Controls. OMICS: A Journal of Integrative Biology 2013; 17(4): 200 doi: 10.1089/omi.2012.0089
|
| 6 |
Maha Alhelf, Rasha M. S. Shoaib, Afaf Elsaid, Nermeen Bastawy, Nanis S. Elbeltagy, Eman T. Salem, Sherif Refaat, Eman H. Abuelnadar. Prognostic significance of the genetic variant of lymphotoxin alpha (p.Thr60Asn) in egyptian patients with advanced hepatocellular carcinoma. Molecular Biology Reports 2023; 50(5): 4317 doi: 10.1007/s11033-023-08281-z
|
| 7 |
Zhenfeng Deng, Jilong Wang, Banghao Xu, Zongrui Jin, Guolin Wu, Jingjing Zeng, Minhao Peng, Ya Guo, Zhang Wen. Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2408348
|
| 8 |
Wei-Ping Lee, Keng-Hsin Lan, Chung-Pin Li, Yee Chao, Han-Chieh Lin, Shou-Dong Lee. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016; 1862(4): 837 doi: 10.1016/j.bbadis.2015.12.020
|
| 9 |
Lijuan Li, Jian Wu, Xiutian Sima, Peng Bai, Wei Deng, Xueke Deng, Lin Zhang, Linbo Gao. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumor Biology 2013; 34(3): 1919 doi: 10.1007/s13277-013-0736-9
|
| 10 |
Host Factors in the Natural History of Chronic Hepatitis B: Role of Genetic Determinants. International Journal of Hepatology 2022; 2022: 1 doi: 10.1155/2022/6046677
|
| 11 |
Sandra Rebouissou, Jean-Charles Nault. Advances in molecular classification and precision oncology in hepatocellular carcinoma. Journal of Hepatology 2020; 72(2): 215 doi: 10.1016/j.jhep.2019.08.017
|
| 12 |
Hongde Zhen, Xiang Qian, Xiaoxuan Fu, Zhuo Chen, Aiqin Zhang, Lei Shi. Regulation of Shaoyao Ruangan Mixture on Intestinal Flora in Mice With Primary Liver Cancer. Integrative Cancer Therapies 2019; 18: 153473541984317 doi: 10.1177/1534735419843178
|
| 13 |
Yujin Hoshida. Molecular epidemiology of hepatocellular carcinoma. Clinical Liver Disease 2012; 1(6): 177 doi: 10.1002/cld.117
|
| 14 |
Dawei Chen, Shuanghai Liu, Sheng Chen, Zhaowen Wang, Zehua Wu, Kai Ma, Junwei Fan, Zhihai Peng. Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation. International Journal of Clinical Oncology 2016; 21(6): 1111 doi: 10.1007/s10147-016-1001-1
|
| 15 |
Sayeh Ezzikouri, Soumaya Benjelloun, Pascal Pineau. Human genetic variation and the risk of hepatocellular carcinoma development. Hepatology International 2013; 7(3): 820 doi: 10.1007/s12072-013-9463-y
|
| 16 |
Pierre Nahon, Jessica Zucman-Rossi. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. Journal of Hepatology 2012; 57(3): 663 doi: 10.1016/j.jhep.2012.02.035
|
| 17 |
Dayse Celia Aroucha, Rodrigo Feliciano Carmo, Luydson Richardson Silva Vasconcelos, Raul Emidio Lima, Taciana Furtado Mendonça, Lucia Elena Arnez, Maria do Socorro Mendonça Cavalcanti, Maria Tereza Cartaxo Muniz, Marcilio Lins Aroucha, Erika Rabelo Siqueira, Luciano Beltrão Pereira, Patrícia Moura, Leila Maria Moreira Beltrão Pereira, Maria Rosangela Coêlho. TNF‐α and IL‐10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals. Journal of Medical Virology 2016; 88(9): 1587 doi: 10.1002/jmv.24501
|
| 18 |
Chun Gao. Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma. World Journal of Hepatology 2016; 8(27): 1119-1127 doi: 10.4254/wjh.v8.i27.1119
|
| 19 |
Ji-Sheng Jing, Zhuo-Qun Wang, Ying-Kui Jiang, Xin-Yun Zhang, Wei-Min Jiang. Association of cytokine gene polymorphisms with chronic hepatitis C virus genotype 1b infection in Chinese Han population. Medicine 2020; 99(38): e22362 doi: 10.1097/MD.0000000000022362
|
| 20 |
Teresa Tan Yen Mei, Htar Htar Aung, Wong Siew Tung, Cho Naing. Association between IL-10 gene polymorphisms (− 1082 A/G, -819 T/C, -592 A/C) and hepatocellular carcinoma: a meta-analysis and trial sequential analysis. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11323-1
|
| 21 |
Li-Ming Wu, Lin Zhou, Jun Xu, Ba-Jin Wei, Jun Cheng, Xiao Xu, Bin Xi, Hai-Yang Xie, Shu-Sen Zheng. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation. Hepatobiliary & Pancreatic Diseases International 2013; 12(1): 54 doi: 10.1016/S1499-3872(13)60006-5
|
| 22 |
Roberto Díaz-Peña, Patricia Mondelo-Macía, Patricia Castro-Santos. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_46-1
|
| 23 |
Anwayee Das, Kriti Menon. Genetic Perspective of Hepatocellular Carcinoma (HCC) in Asian population - A Review. Indian Journal of Science and Technology 2017; 10(31): 1 doi: 10.17485/ijst/2017/v10i31/75684
|
| 24 |
Bao-Xin Qian, Qing Ye, Xin-Yu Zhao, Tao Han, Feng-Mei Wang, Jie Yang. Meta-Analysis of the Relation BetweenIL10Promoter Polymorphisms and Autoimmune Liver Disease Risk. Genetic Testing and Molecular Biomarkers 2018; 22(5): 302 doi: 10.1089/gtmb.2018.0010
|
| 25 |
Armin Hirbod-Mobarakeh, Mahsima Shabani, Mahsa Keshavarz-Fathi, Farnaz Delavari, Ali Akbar Amirzargar, Behrouz Nikbin, Anton Kutikhin, Nima Rezaei. Cancer Immunology. 2020; : 417 doi: 10.1007/978-3-030-30845-2_20
|
| 26 |
Prajjalendra Barooah, Snigdha Saikia, Manas Jyoti Kalita, Rituraj Bharadwaj, Preeti Sarmah, Mallika Bhattacharyya, Bhabadev Goswami, Subhash Medhi. IL-10 Polymorphisms and Haplotypes Predict Susceptibility to Hepatocellular Carcinoma Occurrence in Patients with Hepatitis C Virus Infection from Northeast India. Viral Immunology 2020; 33(6): 457 doi: 10.1089/vim.2019.0170
|
| 27 |
Sabrina Zidi, Yosra Benothmen, Ikram Sghaier, Ezzeddine Ghazoueni, Amel Mezlini, Bouraoui Slimen, Besma Yacoubi-Loueslati. Association of IL10-1082 and IFN-γ+874 Polymorphisms with Cervical Cancer among Tunisian Women. ISRN Genetics 2014; 2014: 1 doi: 10.1155/2014/706516
|
| 28 |
Alex José de Melo Silva, Juliana Ellen de Melo Gama, Cleonilde Maria de Nascimento, Jessica Paula Lucena, Cicero Jadson da Costa, Camila Juliet Barbosa Fernandes, Danielle Maria Nascimento Moura, Helotonio Carvalho, Sheilla Andrade de Oliveira. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 85 doi: 10.1007/16833_2022_37
|